BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su H, Hu N, Yang HH, Wang C, Takikita M, Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ. Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res. 2011;17:2955-2966. [PMID: 22452939 DOI: 10.1158/1078-0432] [Cited by in Crossref: 110] [Cited by in F6Publishing: 377] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Gan W, Gao N, Gu L, Mo Z, Pang X, Lei Z, Gao Z. Reduction in Intrahepatic cccDNA and Integration of HBV in Chronic Hepatitis B Patients with a Functional Cure. J Clin Transl Hepatol 2023;11:314-22. [PMID: 36643049 DOI: 10.14218/JCTH.2022.00177] [Reference Citation Analysis]
2 Fan S, Wang T, You F, Zhang T, Li Y, Ji C, Han Z, Sheng B, Zhai X, An G, Meng H, Yang L. B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia. Eur J Med Res 2023;28:129. [PMID: 36941687 DOI: 10.1186/s40001-023-01049-y] [Reference Citation Analysis]
3 Sarkar N, Singh A, Kumar P, Kaushik M. Protein kinases: Role of their dysregulation in carcinogenesis, identification and inhibition. Drug Res (Stuttg) 2023. [PMID: 36822216 DOI: 10.1055/a-1989-1856] [Reference Citation Analysis]
4 Zou X, Xu Q, You R, Yin G. Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance. J Hepatocell Carcinoma 2023;10:267-79. [PMID: 36815093 DOI: 10.2147/JHC.S399874] [Reference Citation Analysis]
5 Liao Y, Liao Y, Li J, Li Y, Fan Y. The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis. Breast Cancer (Dove Med Press) 2023;15:135-46. [PMID: 36816839 DOI: 10.2147/BCTT.S395984] [Reference Citation Analysis]
6 Suman SK, Mukherjee A, Pandey U, Chakraborty A, Rakshit S, Tawate M, Sarma HD. (68)Ga-Labeled Trastuzumab Fragments for ImmunoPET Imaging of Human Epidermal Growth Factor Receptor 2 Expression in Solid Cancers. Cancer Biother Radiopharm 2023;38:38-50. [PMID: 36413344 DOI: 10.1089/cbr.2022.0042] [Reference Citation Analysis]
7 Zhou L, Yang XQ, Zhao GY, Wang FJ, Liu X. Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer. Front Immunol 2023;14:1044353. [PMID: 36776899 DOI: 10.3389/fimmu.2023.1044353] [Reference Citation Analysis]
8 Wang HK, Wei Q, Yang YL, Lu TY, Yan Y, Wang F. Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study. Cancer Cell Int 2023;23:13. [PMID: 36707809 DOI: 10.1186/s12935-023-02856-3] [Reference Citation Analysis]
9 Zhang B, Yuan Q, Zhang B, Li S, Wang Z, Liu H, Meng F, Chen X, Shang D. Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer. Front Endocrinol (Lausanne) 2022;13:1078424. [PMID: 36743929 DOI: 10.3389/fendo.2022.1078424] [Reference Citation Analysis]
10 Passarelli A, Ventriglia J, Pisano C, Cecere SC, Napoli MD, Rossetti S, Tambaro R, Tarotto L, Fiore F, Farolfi A, Bartoletti M, Pignata S. The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a PIK3CA-mutated endometrial cancer. Front Oncol 2022;12:1088962. [PMID: 36713525 DOI: 10.3389/fonc.2022.1088962] [Reference Citation Analysis]
11 Park M, Kang KW, Kim JW. The role and application of transcriptional repressors in cancer treatment. Arch Pharm Res 2023;46:1-17. [PMID: 36645575 DOI: 10.1007/s12272-023-01427-4] [Reference Citation Analysis]
12 Zhan G, Hu J, Da S, Weng J, Zhou C, Wen F, Liu S, Fang F, Shen E, Zhou Q, Luo P, Xu M, Zhan D, Su Y. A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer. Front Endocrinol (Lausanne) 2023;14:1110624. [PMID: 36742383 DOI: 10.3389/fendo.2023.1110624] [Reference Citation Analysis]
13 Davenport AA, Lu Y, Gallegos CA, Massicano AVF, Heinzman KA, Song PN, Sorace AG, Cogan NG. Mathematical Model of Triple-Negative Breast Cancer in Response to Combination Chemotherapies. Bull Math Biol 2022;85:7. [PMID: 36542180 DOI: 10.1007/s11538-022-01108-1] [Reference Citation Analysis]
14 Shen Z, Qiu B, Li L, Yang B, Li G. Targeted therapy of RET fusion-positive non-small cell lung cancer. Front Oncol 2022;12:1033484. [PMID: 36582799 DOI: 10.3389/fonc.2022.1033484] [Reference Citation Analysis]
15 Sasa K, Saito T, Kurihara T, Hasegawa N, Sano K, Kubota D, Akaike K, Okubo T, Hayashi T, Takagi T, Ishijima M, Suehara Y. Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma. Technol Cancer Res Treat 2022;21:15330338221138217. [PMID: 36475952 DOI: 10.1177/15330338221138217] [Reference Citation Analysis]
16 Rao MMV, Likith M, Kavya R, Hariprasad TPN. Plectin as a putative novel biomarker for breast cancer: an in silico study. Netw Model Anal Health Inform Bioinforma 2022;11:49. [DOI: 10.1007/s13721-022-00392-0] [Reference Citation Analysis]
17 Cioffi R, Galli F, Rabaiotti E, Candiani M, Pella F, Candotti G, Bocciolone L, De Marzi P, Mangili G, Bergamini A. Experimental drugs for fallopian cancer: promising agents in the clinical trials and key stumbling blocks for researchers. Expert Opin Investig Drugs 2022;31:1339-57. [PMID: 36537209 DOI: 10.1080/13543784.2022.2160313] [Reference Citation Analysis]
18 Shen Q, Zhang C, Jiang X, Li J, Liu F, Zhang X, En G, Pang B. Emerging current trends and research focus related to pancreatic cancer metabolism: A bibliometric and visualized analysis. Front Oncol 2022;12:1009700. [PMID: 36505775 DOI: 10.3389/fonc.2022.1009700] [Reference Citation Analysis]
19 Ngamkham J, Siritutsoontorn S, Saisomboon S, Vaeteewoottacharn K, Jitrapakdee S. CRISPR Cas9-mediated ablation of pyruvate carboxylase gene in colon cancer cell line HT-29 inhibits growth and migration, induces apoptosis and increases sensitivity to 5-fluorouracil and glutaminase inhibitor. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.966089] [Reference Citation Analysis]
20 Rizzo S, Raia G, Del Grande M, Gasparri ML, Colombo I, Manganaro L, Papadia A, Del Grande F. Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1057631] [Reference Citation Analysis]
21 Huang Y, Zhai Y, Wu M, Chang C, Luo J, Hong D, Zhao Q, Dai Y, Liu J. Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance. DDDT 2022;Volume 16:3817-3828. [DOI: 10.2147/dddt.s376474] [Reference Citation Analysis]
22 Hong T, Su W, Pan Y, Tian C, Lei G. Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma. Front Immunol 2022;13:951459. [DOI: 10.3389/fimmu.2022.951459] [Reference Citation Analysis]
23 Gan Y, Yang Y, Wu Y, Li T, Liu L, Liang F, Qi J, Liang P, Pan D. Comprehensive transcriptomic analysis of immune-related eRNAs associated with prognosis and immune microenvironment in melanoma. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.917061] [Reference Citation Analysis]
24 Pavan SR, Prabhu A. Advanced cisplatin nanoformulations as targeted drug delivery platforms for lung carcinoma treatment: a review. J Mater Sci. [DOI: 10.1007/s10853-022-07649-z] [Reference Citation Analysis]
25 Xiao X, Wang Y, Zou Z, Yang Y, Wang X, Xin X, Tu S, Li Y. Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies. Front Immunol 2022;13:954235. [PMID: 36091028 DOI: 10.3389/fimmu.2022.954235] [Reference Citation Analysis]
26 Li H, Zhang M, Wang X, Liu Y, Li X. Advancements in the treatment of metastatic hormone-sensitive prostate cancer. Front Oncol 2022;12:913438. [DOI: 10.3389/fonc.2022.913438] [Reference Citation Analysis]
27 Fremond S, Koelzer VH, Horeweg N, Bosse T. The evolving role of morphology in endometrial cancer diagnostics: From histopathology and molecular testing towards integrative data analysis by deep learning. Front Oncol 2022;12:928977. [DOI: 10.3389/fonc.2022.928977] [Reference Citation Analysis]
28 Carmenate T, Montalvo G, Lozada SL, Rodriguez Y, Ortiz Y, Díaz C, Avellanet J, Kim J, Surh CD, Graça L, León K. The antitumor effect induced by an IL-2 ‘no-alpha’ mutein depends on changes in the CD8+ T lymphocyte/Treg cell balance. Front Immunol 2022;13:974188. [DOI: 10.3389/fimmu.2022.974188] [Reference Citation Analysis]
29 Qin Y, Zhu L, Zhao W, Wang J, Wang H. Review of Radiomics- and Dosiomics-based Predicting Models for Rectal Cancer. Front Oncol 2022;12:913683. [DOI: 10.3389/fonc.2022.913683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Zhao Y, Ji Z, Li J, Zhang S, Wu C, Zhang R, Guo Z. Growth hormone associated with treatment efficacy of immune checkpoint inhibitors in gastric cancer patients. Front Oncol 2022;12:917313. [DOI: 10.3389/fonc.2022.917313] [Reference Citation Analysis]
31 Kamali Dolatabadi R, Fazeli H, Emami MH, Karbasizade V, Maghool F, Fahim A, Rahimi H. Phenotypicand Genotypic Characterization of Clinical Isolates of Intracellular Adherent–Invasive Escherichia coli Among Different Stages, Family History, and Treated Colorectal Cancer Patients in Iran. Front Cell Infect Microbiol 2022;12:938477. [DOI: 10.3389/fcimb.2022.938477] [Reference Citation Analysis]
32 Nakahama K, Kaneda H, Osawa M, Izumi M, Yoshimoto N, Sugimoto A, Nagamine H, Ogawa K, Matsumoto Y, Sawa K, Tani Y, Mitsuoka S, Watanabe T, Asai K, Kawaguchi T. Association of thyroid transcription factor-1 with the efficacy of immune-checkpoint inhibitors in patients with advanced lung adenocarcinoma. Thorac Cancer 2022. [PMID: 35808895 DOI: 10.1111/1759-7714.14560] [Reference Citation Analysis]
33 Zuo W, Zhao C, Li Y, Sun H, Ma G, Liu Y, Kang S. High Expression of PARP1 in Tumor and Stroma Cells Predicts Different Prognosis and Platinum Resistance in Patients With Advanced Epithelial Ovarian Cancer. Front Oncol 2022;12:931445. [DOI: 10.3389/fonc.2022.931445] [Reference Citation Analysis]
34 Kiseleva MP, Borisova LM, Smirnova GB, Borisova YA, Lantsova AV, Sanarova EV, Nikolaeva LL, Ektova LV, Komarova MV. Antiproliferative activity of a new derivative from the class of N-glycoside of indolo[2,3-a]pyrrolo[3,4-c]carbazoles. RRP 2022;8:49-57. [DOI: 10.3897/rrpharmacology.8.79424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 К T, Dong JH, Wang D, Li F, Zhang ZT. MIR-147B Regulated Proliferation and Apoptosis of Gastric Cancer Cells by Targeting CPEB2 Via the PTEN Pathway. Balkan J Med Genet 2022;25:61-70. [PMID: 36880039 DOI: 10.2478/bjmg-2022-0007] [Reference Citation Analysis]
36 Quazi S. Telomerase gene therapy: a remission toward cancer. Med Oncol 2022;39. [DOI: 10.1007/s12032-022-01702-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Bethel N, Asrar H, Dacosta J, Savopoulos A, Shaaban H. A Rare Case of Solitary Plasmacytoma Arising From the Sternum. Cureus. [DOI: 10.7759/cureus.23819] [Reference Citation Analysis]
38 Zhou R, Zhu X, Peng Y, Zhong L, Peng L, Yang B, Meng Y, Chen X, Lu Y. Clinical Impact of 11q13.3 Amplification on Immune Cell Infiltration and Prognosis in Breast Cancer. IJGM 2022;Volume 15:4037-52. [DOI: 10.2147/ijgm.s360177] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Qian L, Yang F, Lin X, Jiang S, Zhang Y, Tang Y. Pyrroloquinoline quinone ameliorates liver injury in mice induced by cyclophosphamide. Environ Sci Pollut Res Int 2022;29:30383-93. [PMID: 34997497 DOI: 10.1007/s11356-021-17990-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
40 Hong E, Chen XE, Mao J, Zhou JJ, Chen L, Xu JY, Tao W. Sequential occurrence of T790M mutation and small cell lung cancer transformation in EGFR-positive lung adenocarcinoma: A case report. World J Clin Cases 2022; 10(9): 2834-2841 [DOI: 10.12998/wjcc.v10.i9.2834] [Reference Citation Analysis]
41 Ying L, Yao Y, Lv H, Lu G, Zhang Q, Yang Y, Zhou J. IL-17A contributes skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway. Am J Physiol Cell Physiol 2022. [PMID: 35319902 DOI: 10.1152/ajpcell.00463.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 He Y, Hu B, Zhu C, Xu W, Ge Y, Hao X, Dong B, Chen X, Dong Q, Zhou X. A Novel Multimodal Radiomics Model for Predicting Prognosis of Resected Hepatocellular Carcinoma. Front Oncol 2022;12:745258. [DOI: 10.3389/fonc.2022.745258] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Pang ES, Daraj G, Balka KR, De Nardo D, Macri C, Hochrein H, Masterman K, Tan PS, Shoppee A, Magill Z, Jahan N, Bafit M, Zhan Y, Kile BT, Lawlor KE, Radford KJ, Wright MD, O’keeffe M. Discordance in STING-Induced Activation and Cell Death Between Mouse and Human Dendritic Cell Populations. Front Immunol 2022;13:794776. [DOI: 10.3389/fimmu.2022.794776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Dang Y, Yu J, Zhao S, Cao X, Wang Q. HOXA7 promotes the metastasis of KRAS mutant colorectal cancer by regulating myeloid-derived suppressor cells. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02519-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Wu S, Li G, Guan W, Zhao H, Wang J, Zhou Y, Zhou Y, Shi B. Low Heart Rate Variability Predicts Poor Overall Survival of Lung Cancer Patients With Brain Metastases. Front Neurosci 2022;16:839874. [DOI: 10.3389/fnins.2022.839874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Ionica E, Gaina G, Tica M, Chifiriuc M, Gradisteanu-pircalabioru G. Contribution of Epithelial and Gut Microbiome Inflammatory Biomarkers to the Improvement of Colorectal Cancer Patients’ Stratification. Front Oncol 2022;11:811486. [DOI: 10.3389/fonc.2021.811486] [Reference Citation Analysis]
47 Misaki R, Iwasaki M, Takechi H, Yamano-Adachi N, Ohashi T, Kajiura H, Fujiyama K. Establishment of serum-free adapted Chinese hamster ovary cells with double knockout of GDP-mannose-4,6-dehydratase and GDP-fucose transporter. Cytotechnology 2022;74:163-79. [PMID: 35185292 DOI: 10.1007/s10616-021-00501-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Gül G, Ince D, Olgun N, Ozer E. PD-L1 and PD-L2 Mutations in Pediatric Hodgkin Lymphoma: Do They Have Any Prognostic Significance? Fetal Pediatr Pathol 2022;41:49-57. [PMID: 32401663 DOI: 10.1080/15513815.2020.1764680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Li M, Younis MH, Zhang Y, Cai W, Lan X. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond. Eur J Nucl Med Mol Imaging. [DOI: 10.1007/s00259-022-05706-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
50 Solayappan M, Azlan A, Khor KZ, Yik MY, Khan M, Yusoff NM, Moses EJ. Utilization of CRISPR-Mediated Tools for Studying Functional Genomics in Hematological Malignancies: An Overview on the Current Perspectives, Challenges, and Clinical Implications. Front Genet 2022;12:767298. [DOI: 10.3389/fgene.2021.767298] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Dey S, Singh AK, Singh AK, Rawat K, Banerjee J, Agnihotri V, Upadhaya D. Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention. Med Oncol 2022;39. [DOI: 10.1007/s12032-021-01633-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Meichner K, Mccleary-wheeler AL, Mochizuki H, Stokol T. Editorial: Comparative Oncology–Advances in Veterinary Molecular Oncology. Front Vet Sci 2022;8:812856. [DOI: 10.3389/fvets.2021.812856] [Reference Citation Analysis]
53 Feng W, Hou J, Xiang C, Die X, Sun J, Guo Z, Liu W, Wang Y. Correlation of systemic immune-inflammation Index with surgical necrotizing enterocolitis. Front Pediatr 2022;10:1044449. [PMID: 36419917 DOI: 10.3389/fped.2022.1044449] [Reference Citation Analysis]
54 Shaik BB, Katari NK, Krishnan A. Nanostructured Materials for Cancer Diagnosis and Therapeutics. Nanotechnology in the Life Sciences 2022. [DOI: 10.1007/978-3-030-82918-6_9] [Reference Citation Analysis]
55 Jiang Y, Lin L, Lv H, Zhang H, Jiang L, Ma F, Wang Q, Ma X, Yu S. . MBE 2022;19:7178-200. [DOI: 10.3934/mbe.2022339] [Reference Citation Analysis]
56 Fang Z, Su Y, Sun H, Ge M, Qi Z, Hao C, Qian S, Ma X. Case Report : Li-Fraumeni Syndrome with Central Nervous System Tumors in Two Siblings. BMC Pediatr 2021;21. [DOI: 10.1186/s12887-021-03070-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
57 Semiglazov VF, Dzhelialova MA. Adjuvant and neoadjuvant therapy of ER+ / HER2– breast cancer. Medicinskij alfavit 2021;1:7-12. [DOI: 10.33667/2078-5631-2021-31-7-12] [Reference Citation Analysis]
58 PIK3CA mutation: changing the paradigm of HR+ HER2-negative metastatic breast cancer therapy. Review of the Novartis Pharma satellite symposium, held as part of a virtual forum dedicated to the diagnosis and treatment of patients with hormone-dependent HER2-negative advanced breast cancer with a PIK3CA gene mutation. April 23, 2021. J Mod Onco 2021;23:269-274. [DOI: 10.26442/18151434.2021.2.200923] [Reference Citation Analysis]
59 Koca B, Yildirim M, Kuru B. Prognostic Factors Affecting Disease-Free Survival in Triple-Negative Breast Cancer and Impact of Ki-67. Indian J Surg 2021. [DOI: 10.1007/s12262-021-03066-9] [Reference Citation Analysis]
60 Hofer S, Le Rhun E. Leptomeningeal metastases from solid tumours. memo 2021;14:192-197. [DOI: 10.1007/s12254-021-00693-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Dash RP, Thomas JA, Rosenfeld C, Srinivas NR. Protein Binding and Stability of Drug Candidates: The Achilles' Heel in In Vitro Potency Assays. Eur J Drug Metab Pharmacokinet 2020;45:427-32. [PMID: 32270425 DOI: 10.1007/s13318-020-00619-3] [Reference Citation Analysis]
62 Singh RD, Kumbhakar P, Pal S, Khannam SK, Kumbhakar P. Investigating morphology-dependent antibacterial property of ZnO nanoparticles and developing an insight into oxidative stress generation and cellular response. Biologia 2021;76:1339-1348. [DOI: 10.1007/s11756-021-00690-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Ohata EF, Chagas JVSD, Bezerra GM, Hassan MM, de Albuquerque VHC, Filho PPR. A novel transfer learning approach for the classification of histological images of colorectal cancer. J Supercomput 2021;77:9494-519. [DOI: 10.1007/s11227-020-03575-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
64 Zhu X, Lazow MA, Schafer A, Bartlett A, Senthil Kumar S, Mishra DK, Dexheimer P, DeWire M, Fuller C, Leach JL, Fouladi M, Drissi R. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathol Commun 2021;9:14. [PMID: 33431066 DOI: 10.1186/s40478-020-01107-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
65 Gan L, Gan Z, Dan Y, Li Y, Zhang P, Chen S, Ye Z, Pan T, Wan C, Hu X, Yu Y. Tetrazanbigen Derivatives as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Partial Agonists: Design, Synthesis, Structure-Activity Relationship, and Anticancer Activities. J Med Chem 2021;64:1018-36. [PMID: 33423463 DOI: 10.1021/acs.jmedchem.0c01512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
66 Mukherjee TK, Malik P, Hoidal JR. Receptor for Advanced Glycation End Products (RAGE) and Its Polymorphic Variants as Predictive Diagnostic and Prognostic Markers of NSCLCs: a Perspective. Curr Oncol Rep 2021;23:12. [PMID: 33399986 DOI: 10.1007/s11912-020-00992-x] [Reference Citation Analysis]
67 Fujimoto N. Systemic Chemotherapy for Unresectable Pleural Mesothelioma from Front Line to Salvage Treatment: How Can We Treat the Patients Failed to PD-1/PD-L1 Inhibitors? Malignant Pleural Mesothelioma 2021. [DOI: 10.1007/978-981-15-9158-7_22] [Reference Citation Analysis]
68 Akhtar K, Javed Y, Akhtar MI, Shad NA. Applications of Iron Oxide Nanoparticles in the Magnetic Resonance Imaging for the Cancer Diagnosis. Nanopharmaceuticals: Principles and Applications Vol. 1 2021. [DOI: 10.1007/978-3-030-44925-4_3] [Reference Citation Analysis]
69 Pang S, Soon ML, Shameli K, Janarthanan P, Teow S. Delivery of Drug Payloads to Organs and Organ-Systems. Nanotechnology in the Life Sciences 2021. [DOI: 10.1007/978-3-030-61021-0_11] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Pavlova VY, Livadnyi E. CAR-T Technology and New Opportunities for Tumor Treatment. Клиническая онкогематология 2021;14:149-156. [DOI: 10.21320/2500-2139-2021-14-1-149-156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Italiano A. New insights into the clinical management of advanced gastrointestinal stromal tumors. Expert Opin Pharmacother 2021;22:439-47. [PMID: 33307872 DOI: 10.1080/14656566.2020.1828346] [Reference Citation Analysis]
72 Li M, Li G, Kiyokawa J, Tirmizi Z, Richardson LG, Ning J, Das S, Martuza RL, Stemmer-Rachamimov A, Rabkin SD, Wakimoto H. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma. Acta Neuropathol Commun 2020;8:221. [PMID: 33308315 DOI: 10.1186/s40478-020-01096-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
73 Ignatova E, Seriak D, Fedyanin M, Tryakin A, Pokataev I, Menshikova S, Vakhabova Y, Smirnova K, Tjulandin S, Ajani JA. Epstein-Barr virus-associated gastric cancer: disease that requires special approach. Gastric Cancer 2020;23:951-60. [PMID: 32514646 DOI: 10.1007/s10120-020-01095-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
74 Malinina EA, Avdeeva VV, Korolenko SE, Nefedov SE, Goeva LV, Kuznetsov NT. Features of Formation of Mononuclear and Binuclear Copper(II) Complexes with 2,2'-Bipyridyl and closo-Decaborate Anion. Russ J Inorg Chem 2020;65:1343-50. [DOI: 10.1134/s0036023620090119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
75 Biederstädt A, Hassan Z, Schneeweis C, Schick M, Schneider L, Muckenhuber A, Hong Y, Siegers G, Nilsson L, Wirth M, Dantes Z, Steiger K, Schunck K, Langston S, Lenhof HP, Coluccio A, Orben F, Slawska J, Scherger A, Saur D, Müller S, Rad R, Weichert W, Nilsson J, Reichert M, Schneider G, Keller U. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype. Gut 2020;69:1472-82. [PMID: 32001555 DOI: 10.1136/gutjnl-2018-317856] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
76 Moyad MA. Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part III. Curr Urol Rep 2020;21:22. [PMID: 32367257 DOI: 10.1007/s11934-020-00972-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Kharlamovа OS, Nikolaev KY, Ragino YI, Voevoda MI. [Surfactant proteins A and D: role in the pathogenesis of community-acquired pneumonia and possible predictive perspectives]. Ter Arkh 2020;92:109-15. [PMID: 32598802 DOI: 10.26442/00403660.2020.03.000275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 Frustaci AM, Tedeschi A, Deodato M, Zamprogna G, Cairoli R, Montillo M. Duvelisib for the treatment of chronic lymphocytic leukemia. Expert Opin Pharmacother 2020;21:1299-309. [PMID: 32292084 DOI: 10.1080/14656566.2020.1751123] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
79 Sun F, Fang X, Wang X. Signal Pathways and Therapeutic Prospects of Diffuse Large B Cell Lymphoma. Anticancer Agents Med Chem 2019;19:2047-59. [PMID: 32009599 DOI: 10.2174/1871520619666190925143216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
80 Tendl KA, Bago-horvath Z. Molecular profiling in breast cancer—ready for clinical routine? memo 2020;13:445-9. [DOI: 10.1007/s12254-020-00578-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
81 Pina-oviedo S, Khogeer HA, Tang G, Miranda RN. Hematopathology. Oncological Surgical Pathology 2020. [DOI: 10.1007/978-3-319-96681-6_17] [Reference Citation Analysis]
82 Peng YZ, Yang LJ, Lo HH, Law BYK, Wong VKW. Tumor Therapeutic Modes. New Nanomaterials and Techniques for Tumor-targeted Systems 2020. [DOI: 10.1007/978-981-15-5159-8_6] [Reference Citation Analysis]
83 Smekalenkov OA, Ptashnikov DA, Zaborovskii NS, Mikhaylov DA, Masevnin SV, Denisov AA. Risk Factors for Infectious Complications after Surgical Treatment of Spinal Metastases in Patients with Breast and Kidney Cancer. Traumatology and Orthopedics of Russia 2019;25:126-133. [DOI: 10.21823/2311-2905-2019-25-4-126-133] [Reference Citation Analysis]
84 Shrader-Frechette K, Meade T. Using routine, independent, scientific-data audits as an early-warning for potentially fraudulent toxic-site cleanup: PCE, TCE, and other VOCs at the former Naval-Ordnance Test Station, Pasadena, California. Account Res 2020;27:1-31. [PMID: 31838886 DOI: 10.1080/08989621.2019.1695200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
85 Yu. Rykov M, R. Sengapova E. Treatment of Children with Osteosarcoma. Osteosarcoma – Diagnosis, Mechanisms, and Translational Developments 2019. [DOI: 10.5772/intechopen.83756] [Reference Citation Analysis]
86 Li Y, You MJ, Yang Y, Hu D, Tian C. The Role of Tumor-Associated Macrophages in Leukemia. Acta Haematol 2020;143:112-7. [PMID: 31288222 DOI: 10.1159/000500315] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
87 Pondé NF, Zardavas D, Piccart M. Progress in adjuvant systemic therapy for breast cancer. Nat Rev Clin Oncol 2019;16:27-44. [PMID: 30206303 DOI: 10.1038/s41571-018-0089-9] [Cited by in Crossref: 99] [Cited by in F6Publishing: 109] [Article Influence: 24.8] [Reference Citation Analysis]
88 Rykov MY, Sengapova ER. Osteosarcoma – on the way to personalized therapy. Part II: personalized therapy of the future. Ross vestn perinatol pediatr 2019;64:28-36. [DOI: 10.21508/1027-4065-2019-64-3-28-36] [Reference Citation Analysis]
89 Mikhaleuskaya TM, Valochnik AV, Konoplya NE, Bydanov OI. The Clinical Significance of Molecular Markers — BRAF V600E Mutations and CDKN2A Deletions — in Low-Grade Pediatric Gliomas: Cohort Study. Oncopediatria 2019;6:34-44. [DOI: 10.15690/onco.v6i1/1996] [Reference Citation Analysis]
90 Sun M, Ma N, He T, Johnston LJ, Ma X. Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR). Critical Reviews in Food Science and Nutrition 2020;60:1760-8. [DOI: 10.1080/10408398.2019.1598334] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 16.3] [Reference Citation Analysis]
91 Zhang LQ, Lu N. Role of miR-200c in early diagnosis of gastric cancer: Current status and prospects. Shijie Huaren Xiaohua Zazhi 2019; 27(6): 382-388 [DOI: 10.11569/wcjd.v27.i6.382] [Reference Citation Analysis]
92 Biray Avci Ç, Göker Bağca B. Epigallokateşin-3- gallat uygulamasına bağlı olarak kronik miyeloid lösemi hücrelerinde genetik ve epigenetik otofaji regülatörlerinin ekspresyon değişimlerinin değerlendirilmesi. SDÜ Tıp Fakültesi Dergisi 2019. [DOI: 10.17343/sdutfd.469847] [Reference Citation Analysis]
93 Lüftinger R, Azizi AA, Mann G. Früherkennung kindlicher Tumoren. Monatsschr Kinderheilkd 2019;167:155-167. [DOI: 10.1007/s00112-018-0636-6] [Reference Citation Analysis]
94 Gunda V, Kumar S, Dasgupta A, Singh PK. Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells. Methods Mol Biol 2018;1742:95-105. [PMID: 29330793 DOI: 10.1007/978-1-4939-7665-2_9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
95 Rao F, Rizzolio F, Rizzardi C, Perin T, Canzonieri V. Noncoding RNA in Gastric Cancer with Potential Prognostic and Predictive Role. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_11] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Solopova O, Misyurin VA. Bispecific Antibodies in Clinical Practice and Clinical Trials (Literature Review). Клиническая онкогематология 2019;12:25-44. [DOI: 10.21320/2500-2139-2019-12-2-125-144] [Reference Citation Analysis]
97 Ormanns S. Personalisierte Krebsmedizin. Pathologe 2018;39:221-224. [DOI: 10.1007/s00292-018-0539-2] [Reference Citation Analysis]
98 Spagnuolo A, Maione P, Gridelli C. Evolution in the treatment landscape of non-small cell lung cancer with ALK gene alterations: from the first- to third-generation of ALK inhibitors. Expert Opinion on Emerging Drugs 2018;23:231-41. [DOI: 10.1080/14728214.2018.1527902] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
99 Raman V, Aryal UK, Hedrick V, Ferreira RM, Fuentes Lorenzo JL, Stashenko EE, Levy M, Levy MM, Camarillo IG. Proteomic Analysis Reveals That an Extract of the Plant Lippia origanoides Suppresses Mitochondrial Metabolism in Triple-Negative Breast Cancer Cells. J Proteome Res 2018;17:3370-83. [DOI: 10.1021/acs.jproteome.8b00255] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
100 Ramos MC, Genilloud O, Reyes F, Vicente F. Drug Discovery from Natural Products for Pancreatic Cancer. Advances in Pancreatic Cancer 2018. [DOI: 10.5772/intechopen.76399] [Reference Citation Analysis]
101 Hegarty A, Furlong Y. Neuropsychiatry: Aspects of Childhood Cranial Tumours. Brain Tumors - An Update 2018. [DOI: 10.5772/intechopen.75679] [Reference Citation Analysis]
102 Nakamoto H, Amaya Y, Komatsu T, Suzuki T, Dohmae N, Nakamura Y, Jantan I, Miyata Y. Stimulation of the ATPase activity of Hsp90 by zerumbone modification of its cysteine residues destabilizes its clients and causes cytotoxicity. Biochemical Journal 2018;475:2559-76. [DOI: 10.1042/bcj20180230] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
103 Shen Y, Shen Y, Liu J, Shi JM, Ding J. Significance of expression of EIF3h, MMP-10 and MMP-11 in colonic adenocarcinoma. Shijie Huaren Xiaohua Zazhi 2018; 26(14): 834-841 [DOI: 10.11569/wcjd.v26.i14.834] [Reference Citation Analysis]
104 Driscoll JJ, Brailey M. Emerging small molecule approaches to enhance the antimyeloma benefit of proteasome inhibitors. Cancer Metastasis Rev 2017;36:585-98. [PMID: 29052093 DOI: 10.1007/s10555-017-9698-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
105 Cui L, Zhao X, Hu S. SOX Genes and Cancer. Gene Expression and Regulation in Mammalian Cells - Transcription From General Aspects 2018. [DOI: 10.5772/intechopen.72433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
106 Butt SU, Malik L. Role of immunotherapy in bladder cancer: past, present and future. Cancer Chemother Pharmacol 2018;81:629-45. [PMID: 29368051 DOI: 10.1007/s00280-018-3518-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
107 Yu C, Xiang Y, Liao X, Zhang X, Li H, Li J, Zhang T. Construction and Functional Analysis of Luciferase Reporter Plasmid Containing Vimentin Gene Promoter. Lecture Notes in Electrical Engineering 2018. [DOI: 10.1007/978-981-10-4801-2_85] [Reference Citation Analysis]
108 Diehl JA, Knudsen KE. Splice Variants and Phosphorylated Isoforms of Cyclin D1 in Tumorigenesis. D-type Cyclins and Cancer 2018. [DOI: 10.1007/978-3-319-64451-6_4] [Reference Citation Analysis]
109 Gneusheva AA, Verovsky VE, Zykova EV, Ostrovsky OV. Concordance of changes in the extracellular DNA of blood plasma and DNA of tumor tissue using the example of EGFR gene mutations in patients with non-small cell lung cancer. Lab sluzh 2018;7:19. [DOI: 10.17116/labs2018704119] [Reference Citation Analysis]
110 Misyurin V. Theory and Practice of Immunotherapy Directed against the PRAME Antigen. Клиническая онкогематология 2018;11:138-149. [DOI: 10.21320/2500-2139-2018-11-2-138-149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
111 Xing S, Zheng X, Zeng T, Zeng MS, Zhong Q, Cao YS, Pan KL, Wei C, Hou F, Liu WL. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival. World J Gastroenterol 2017; 23(43): 7693-7704 [PMID: 29209110 DOI: 10.3748/wjg.v23.i43.7693] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
112 Popova OP, Bogomazova SY, Ivanov AA. [Role of tenascin С in triple-negative breast cancer]. Arkh Patol 2017;79:10-5. [PMID: 29027523 DOI: 10.17116/patol201779510-15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
113 Martini G, Troiani T, Cardone C, Vitiello P, Sforza V, Ciardiello D, Napolitano S, Della Corte CM, Morgillo F, Raucci A, Cuomo A, Selvaggi F, Ciardiello F, Martinelli E. Present and future of metastatic colorectal cancer treatment: A review of new candidate targets. World J Gastroenterol 2017; 23(26): 4675-4688 [PMID: 28765689 DOI: 10.3748/wjg.v23.i26.4675] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 78] [Article Influence: 11.8] [Reference Citation Analysis]
114 Vartanian AA, Burova OS, Ulasov IV, Baryshnikova MA. The involvement of autophagy in melanoma vasculogenic mimicry. Rossijskij bioterapevtičeskij žurnal 2017;16:66-73. [DOI: 10.17650/1726-9784-2017-16-2-66-73] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
115 Cidon EU. Systemic treatment of hepatocellular carcinoma: Past, present and future. World J Hepatol 2017;9:797-807. [PMID: 28706578 DOI: 10.4254/wjh.v9.i18.797] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
116 Kurubanjerdjit N, Ng K. MicroRNA-Regulated Network Motifs with Drug Association in Lung Cancer. Proceedings of the 6th International Conference on Bioinformatics and Biomedical Science 2017. [DOI: 10.1145/3121138.3121163] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
117 Kelleher FC, Callaghan G, Gallagher C, O’Sullivan H. BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis. World J Gastroenterol 2017; 23(17): 3022-3029 [PMID: 28533659 DOI: 10.3748/wjg.v23.i17.3022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Keskinov AA, Shurin MR, Bukhman VM, Shprakh ZS. IMPACT OF TUMOR-DERIVED FACTORS ON DENDRITIC CELLS IN CANCER. Rossijskij bioterapevtičeskij žurnal 2017;16:12-23. [DOI: 10.17650/1726-9784-2017-16-1-12-23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
119 Fadeev NP, Kharisov RI, Kovan’ko EG, Pustovalov YI, Fadeeva VL. THE STUDY OF ANTITUMOR ACTIVITY OF PHENYLBUTYRATE IN COMBINATION WITH 5-FLUOROURACIL ON MODEL OF EHRLICH CARCINOMA. Rossijskij bioterapevtičeskij žurnal 2017;16:70-75. [DOI: 10.17650/1726-9784-2017-16-1-70-75] [Reference Citation Analysis]
120 Yeung KT, More S, Woodward B, Velculescu V, Husain H. Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer. Mol Diagn Ther 2017;21:375-84. [DOI: 10.1007/s40291-017-0260-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
121 Bauckneht M, Piva R, Sambuceti G, Grossi F, Morbelli S. Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography? World J Radiol 2017; 9(2): 27-33 [PMID: 28298962 DOI: 10.4329/wjr.v9.i2.27] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
122 Chen J, Guo XZ, Li HY, Zhao JJ, Xu WD. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer in vitroWorld J Gastroenterol 2017; 23(5): 817-829 [PMID: 28223726 DOI: 10.3748/wjg.v23.i5.817] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
123 Imamura CK. Optimization of Therapy by Pharmacokinetic–Pharmacodynamic Analyses. Renal Cell Carcinoma 2017. [DOI: 10.1007/978-4-431-55531-5_16] [Reference Citation Analysis]
124 Tumyan GS, Zavodnova I, Kichigina M, Medvedovskaya E. Primary Mediastinal (Thymic) Large B-Cell Lymphoma. Клиническая онкогематология 2017;10:13-24. [DOI: 10.21320/2500-2139-2017-10-1-13-24] [Reference Citation Analysis]
125 Votyakova OM. New Possibilities of Treatment for Relapsed/Refractory Multiple Myeloma: A Literature Review. Клиническая онкогематология 2017;10:425-434. [DOI: 10.21320/2500-2139-2017-10-4-425-434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
126 Dakubo GD. Endometriosis Biomarkers in Body Fluids. Cancer Biomarkers in Body Fluids 2017. [DOI: 10.1007/978-3-319-48360-3_14] [Reference Citation Analysis]
127 Vartanian AA, Baryshnikov KA. THERAPIES TARGETING CANCER STEM CELLS OF THE TUMOR: THE ONE AND ONLY HOPE. Rossijskij bioterapevtičeskij žurnal 2016;15:8-17. [DOI: 10.17650/1726-9784-2016-15-4-8-17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
128 Byrne JA, Labbé C. Striking similarities between publications from China describing single gene knockdown experiments in human cancer cell lines. Scientometrics 2017;110:1471-93. [DOI: 10.1007/s11192-016-2209-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
129 Ejima-yamada K, Oshiro Y, Okamura S, Fujisaki T, Mihashi Y, Tamura K, Fukushige T, Kojima M, Shibuya K, Takeshita M. Epstein–Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders. Virchows Arch 2017;470:205-15. [DOI: 10.1007/s00428-016-2030-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
130 Morscio J, Tousseyn T. Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders. World J Transplant 2016; 6(3): 505-516 [PMID: 27683629 DOI: 10.5500/wjt.v6.i3.505] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
131 Lazăr DC, Tăban S, Cornianu M, Faur A, Goldiş A. New advances in targeted gastric cancer treatment. World J Gastroenterol 2016; 22(30): 6776-6799 [PMID: 27570417 DOI: 10.3748/wjg.v22.i30.6776] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
132 Sforza V, Martinelli E, Ciardiello F, Gambardella V, Napolitano S, Martini G, della Corte C, Cardone C, Ferrara ML, Reginelli A, Liguori G, Belli G, Troiani T. Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer. World J Gastroenterol 2016; 22(28): 6345-6361 [PMID: 27605871 DOI: 10.3748/wjg.v22.i28.6345] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 80] [Article Influence: 10.4] [Reference Citation Analysis]
133 Yang Y, Wang JF, Li P. Role of detection of circulating tumor cells in early diagnosis of pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(18): 2838-2843 [DOI: 10.11569/wcjd.v24.i18.2838] [Reference Citation Analysis]
134 Mishra SK, Kumar BS, Khushu S, Tripathi RP, Gangenahalli G. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging. Contrast Media Mol Imaging 2016;11:350-61. [PMID: 27230705 DOI: 10.1002/cmmi.1698] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
135 Lo PK, Wolfson B, Zhou Q. Cancer stem cells and early stage basal-like breast cancer. World J Obstet Gynecol 2016; 5(2): 150-161 [PMID: 28239564 DOI: 10.5317/wjog.v5.i2.150] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
136 Vtorushin SV, Tarakanova VO, Zavyalova MV. [Molecular biological predictors for kidney cancer]. Arkh Patol 2016;78:56-61. [PMID: 27077146 DOI: 10.17116/patol201678156-61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
137 Berardi R, Torniai M, Savini A, Rinaldi S, Cascinu S. Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? World J Clin Oncol 2016; 7(2): 131-134 [PMID: 27081635 DOI: 10.5306/wjco.v7.i2.131] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
138 Dahiya K, Dhankhar R. Updated overview of current biomarkers in head and neck carcinoma. World J Methodol 2016;6:77-86. [PMID: 27018324 DOI: 10.5662/wjm.v6.i1.77] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
139 Aksenenko MB, Ruksha TG. Sequencing methods in dermatology. Russ J Skin & Ven Dis 2016;19:7-12. [DOI: 10.18821/1560-9588-2016-19-1-7-12] [Reference Citation Analysis]
140 Beeharry MK, Liu WT, Yan M, Zhu ZG. New blood markers detection technology: A leap in the diagnosis of gastric cancer. World J Gastroenterol 2016; 22(3): 1202-1212 [PMID: 26811658 DOI: 10.3748/wjg.v22.i3.1202] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
141 De P, Carlson JH, Leyland-jones B, Dey N. PI3K-AKT-mTOR Pathway Cooperates with the DNA Damage Repair Pathway: Carcinogenesis in Triple-Negative Breast Cancers and Beyond. Cancer Drug Discovery and Development 2016. [DOI: 10.1007/978-3-319-34211-5_3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
142 Mamaev NN, Gudozhnikova Y, Gorbunova A. WT1 Gene Overexpression in Oncohematological Disorders: Theoretical and Clinical Aspects (Literature Review). Клиническая онкогематология 2016;9:257-264. [DOI: 10.21320/2500-2139-2016-9-3-257-264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
143 Shi G, Wu J, Wang P, Song M, Sun L, Tu YJ, Huang XD. Expression of RhoGDI2 and 14-3-3σ in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2015; 23(33): 5282-5289 [DOI: 10.11569/wcjd.v23.i33.5282] [Reference Citation Analysis]
144 Cao CL, Li TY, Cao C, Xiong QQ, Jiang QG, Liu DN. Clinical significance of flotillin-1 overexpression in human gastric cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(32): 5141-5147 [DOI: 10.11569/wcjd.v23.i32.5141] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
145 Grapsa D, Saif MW, Syrigos K. Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go? World J Gastrointest Oncol 2015; 7(10): 172-177 [PMID: 26483872 DOI: 10.4251/wjgo.v7.i10.172] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
146 Liu CX, Ma FZ, Wang J, Li K, Li Q, Lian HF. Overexpression of miR-486-5p suppresses tumor lymphangiogenesis in colorectal carcinoma by targeting neuropilin-2. Shijie Huaren Xiaohua Zazhi 2015; 23(27): 4335-4341 [DOI: 10.11569/wcjd.v23.i27.4335] [Reference Citation Analysis]
147 Sai WL, Chen W, Yao DF, Qiu LW, Wu W, Wang L, Yang JL, Zhang HJ, Zheng WJ. Diagnostic value of combined detection of angiopoietin-2 and Golgi protein 73 in primary liver cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(25): 4032-4040 [DOI: 10.11569/wcjd.v23.i25.4032] [Reference Citation Analysis]
148 Bhatia DR, Dhar P, Mutalik V, Deshmukh SK, Verekar SA, Desai DC, Kshirsagar R, Thiagarajan P, Agarwal V. Anticancer activity of Ophiobolin A, isolated from the endophytic fungus Bipolaris setariae. Nat Prod Res 2016;30:1455-8. [PMID: 26212208 DOI: 10.1080/14786419.2015.1062760] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
149 Zhou Y, Huang WF, Feng Q, Shi SD, Li EL, Li KH, Wu RS, Wu LQ. Toll-like receptor 4 regulates hepatitis B virus related hepatic carcinoma cell proliferation by controlling cyclin-dependent kinase 4/6 expression. Shijie Huaren Xiaohua Zazhi 2015; 23(19): 3029-3037 [DOI: 10.11569/wcjd.v23.i19.3029] [Reference Citation Analysis]
150 Qi B, Lu JG, Yao WJ, Chang TM, Qin XG, Ji YH, Wang TY, Liu SG, Li HC, Liu YZ, Zhao BS. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(22): 6884-6891 [PMID: 26078564 DOI: 10.3748/wjg.v21.i22.6884] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
151 Wang JF, Xie Y, Hu L, Li CR, Li HL. Detection of gastric juice microRNAs for screening and diagnosis of gastric cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(16): 2562-2567 [DOI: 10.11569/wcjd.v23.i16.2562] [Reference Citation Analysis]
152 Bai JA, Xu GF, Yan LJ, Zeng WW, Ji QQ, Wu JD, Tang QY. SGK1 inhibits cellular apoptosis and promotes proliferation via the MEK/ERK/p53 pathway in colitis. World J Gastroenterol 2015; 21(20): 6180-6193 [PMID: 26034353 DOI: 10.3748/wjg.v21.i20.6180] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
153 Yan HC, Wang HB. Significance of expression of ECT2 in gastric cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(14): 2215-2220 [DOI: 10.11569/wcjd.v23.i14.2215] [Reference Citation Analysis]
154 Rao CV, Mohammed A. New insights into pancreatic cancer stem cells. World J Stem Cells 2015;7:547-55. [PMID: 25914762 DOI: 10.4252/wjsc.v7.i3.547] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
155 Liu HY, Qian HH, Zhang XF, Li J, Yang X, Sun B, Ma JY, Chen L, Yin ZF. Improved method increases sensitivity for circulating hepatocellular carcinoma cells. World J Gastroenterol 2015; 21(10): 2918-2925 [PMID: 25780289 DOI: 10.3748/wjg.v21.i10.2918] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
156 Kumagai R, Kohashi K, Takahashi S, Yamamoto H, Hirahashi M, Taguchi K, Nishiyama K, Oda Y. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine. World J Gastroenterol 2015; 21(9): 2700-2710 [PMID: 25759539 DOI: 10.3748/wjg.v21.i9.2700] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
157 Wang YM, Gu ML, Ji F. Succinate dehydrogenase-deficient gastrointestinal stromal tumors. World J Gastroenterol 2015; 21(8): 2303-2314 [PMID: 25741136 DOI: 10.3748/wjg.v21.i8.2303] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
158 Jin EH, Lee DH, Jung SA, Shim KN, Seo JY, Kim N, Shin CM, Yoon H, Jung HC. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer. World J Gastroenterol 2015; 21(2): 571-577 [PMID: 25593477 DOI: 10.3748/wjg.v21.i2.571] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
159 Zhao L, Xu JH. Role of adrenergic receptor signaling pathway in colorectal cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(34): 5285-5290 [DOI: 10.11569/wcjd.v22.i34.5285] [Reference Citation Analysis]
160 Yang XW, Jiang HX, Lu WS, Chen M, Lu DH, Huang XL, Wang JX, Qin SY. Role of Th22 cells in pathogenesis of malignant ascites in patients with hepatic carcinoma. Shijie Huaren Xiaohua Zazhi 2014; 22(33): 5069-5078 [DOI: 10.11569/wcjd.v22.i33.5069] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Lu M, Zheng ST, Liu Q, Liu T, Gao XP, Ilyar∙Sheyhidin, Lu XM. Role of PIK3CA in cell proliferation, migration and apoptosis in human esophageal squamous cell carcinoma cell line Ecal09. Shijie Huaren Xiaohua Zazhi 2014; 22(32): 4893-4900 [DOI: 10.11569/wcjd.v22.i32.4893] [Reference Citation Analysis]
162 Chan AW, Gill RS, Schiller D, Sawyer MB. Potential role of metabolomics in diagnosis and surveillance of gastric cancer. World J Gastroenterol 2014; 20(36): 12874-12882 [PMID: 25278684 DOI: 10.3748/wjg.v20.i36.12874] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
163 Sedda S, Marafini I, Caruso R, Pallone F, Monteleone G. Proteinase activated-receptors-associated signaling in the control of gastric cancer. World J Gastroenterol 2014; 20(34): 11977-11984 [PMID: 25232234 DOI: 10.3748/wjg.v20.i34.11977] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
164 Rossi ML, Rehman AA, Gondi CS. Therapeutic options for the management of pancreatic cancer. World J Gastroenterol 2014; 20(32): 11142-11159 [PMID: 25170201 DOI: 10.3748/wjg.v20.i32.11142] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 93] [Article Influence: 9.4] [Reference Citation Analysis]
165 Verma S, Kesh K, Ganguly N, Jana S, Swarnakar S. Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants. World J Biol Chem 2014; 5(3): 355-376 [PMID: 25225603 DOI: 10.4331/wjbc.v5.i3.355] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
166 Han LL, Lv Y, Guo H, Ruan ZP, Nan KJ. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy. World J Gastroenterol 2014; 20(30): 10249-10261 [PMID: 25132742 DOI: 10.3748/wjg.v20.i30.10249] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
167 Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol 2014; 20(30): 10432-10439 [PMID: 25132759 DOI: 10.3748/wjg.v20.i30.10432] [Cited by in CrossRef: 209] [Cited by in F6Publishing: 236] [Article Influence: 23.2] [Reference Citation Analysis]
168 Zhang T, Cao HL, Luo SJ, Zheng DL, Chen YN. Construction of a gastric cancer cell line with stably silenced expression of CD14. Shijie Huaren Xiaohua Zazhi 2014; 22(22): 3194-3200 [DOI: 10.11569/wcjd.v22.i22.3194] [Reference Citation Analysis]
169 Shi G, Liao JZ, He XX, Sun SB, Huang ML, Yang J, Wu J. Expression of RhoGDI2 and CIAPIN1 in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2014; 22(21): 3106-3112 [DOI: 10.11569/wcjd.v22.i21.3106] [Reference Citation Analysis]
170 Kamiyama H, Noda H, Konishi F, Rikiyama T. Molecular biomarkers for the detection of metastatic colorectal cancer cells. World J Gastroenterol 2014; 20(27): 8928-8938 [PMID: 25083065 DOI: 10.3748/wjg.v20.i27.8928] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
171 Ye QQ, Lu HN, Zhang X, Wang DP, Huang ZG. Analysis of GATA5 and Vimentin methylation in fecal DNA for detection of colorectal cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(20): 2971-2976 [DOI: 10.11569/wcjd.v22.i20.2971] [Reference Citation Analysis]
172 Sun ZQ, Han XN, Wang HJ, Tang Y, Zhao ZL, Qu YL, Xu RW, Liu YY, Yu XB. Prognostic significance of preoperative fibrinogen in patients with colon cancer. World J Gastroenterol 2014; 20(26): 8583-8591 [PMID: 25024612 DOI: 10.3748/wjg.v20.i26.8583] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
173 Gigante M, Cox SN, Ranieri E. Negative and Positive Separation Techniques for the Isolation of Antigen-Specific CD8+ T Cells from Blood and Tumor Tissue. In: Ranieri E, editor. Cytotoxic T-Cells. New York: Springer; 2014. pp. 1-11. [DOI: 10.1007/978-1-4939-1158-5_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
174 Anwar SL, Lehmann U. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. World J Gastroenterol 2014; 20(24): 7894-7913 [PMID: 24976726 DOI: 10.3748/wjg.v20.i24.7894] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 68] [Article Influence: 6.9] [Reference Citation Analysis]
175 Sun D, Qin L, Xu Y, Liu JX, Tian LP, Qian HX. Influence of adriamycin on changes in Nanog, Oct-4, Sox2, ARID1 and Wnt5b expression in liver cancer stem cells. World J Gastroenterol 2014; 20(22): 6974-6980 [PMID: 24944491 DOI: 10.3748/wjg.v20.i22.6974] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
176 Peng Z, Wang CX, Fang EH, Wang GB, Tong Q. Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World J Gastroenterol 2014; 20(18): 5403-5410 [PMID: 24833870 DOI: 10.3748/wjg.v20.i18.5403] [Cited by in CrossRef: 134] [Cited by in F6Publishing: 147] [Article Influence: 14.9] [Reference Citation Analysis]
177 Zhang JZ, Liu Y, Ma YY. Relationship between blood flow assessed by ultrasound, MVD and expression of HIF-1α in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2014; 22(11): 1587-1591 [DOI: 10.11569/wcjd.v22.i11.1587] [Reference Citation Analysis]
178 Bhatnagar S, Katare D, Jain S. Serum-based protein biomarkers for detection of lung cancer. Open Life Sciences 2014;9:341-58. [DOI: 10.2478/s11535-013-0271-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
179 He J, Zeng ZC, Xiang ZL, Yang P. Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis. World J Gastroenterol 2014; 20(11): 3025-3032 [PMID: 24659894 DOI: 10.3748/wjg.v20.i11.3025] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
180 Fu L, Yang YX, Bai YQ, Zhang LD. Abnormal expression of PLAG1 in plasma of patients with hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2014; 22(5): 630-636 [DOI: 10.11569/wcjd.v22.i5.630] [Reference Citation Analysis]
181 Li M, Lian HF, Liu CX, Ma FZ, Xie SY. Prediction and identification of microRNAs involved in regulating neuropilin-2 in colorectal carcinoma. Shijie Huaren Xiaohua Zazhi 2014; 22(5): 624-629 [DOI: 10.11569/wcjd.v22.i5.624] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Chen J, Wu QM, Long H, Zhang H, Chen JH. P162 enhances radiosensitivity of esophageal carcinoma Eca109 cells by inhibiting Hedgehog signaling transcription factor Gli-1. Shijie Huaren Xiaohua Zazhi 2014; 22(5): 615-623 [DOI: 10.11569/wcjd.v22.i5.615] [Reference Citation Analysis]
183 Zhang H, Wu QM, Long H, Chen J, Chen JH. P162 increases radiosensitivity of esophageal cancer cell line Eca109 by inhibiting Chk1/2 expression. Shijie Huaren Xiaohua Zazhi 2014; 22(4): 461-468 [DOI: 10.11569/wcjd.v22.i4.461] [Reference Citation Analysis]
184 Coppedè F, Lopomo A, Spisni R, Migliore L. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. World J Gastroenterol 2014; 20(4): 943-956 [PMID: 24574767 DOI: 10.3748/wjg.v20.i4.943] [Cited by in CrossRef: 167] [Cited by in F6Publishing: 174] [Article Influence: 18.6] [Reference Citation Analysis]
185 Liao GL, Xiao WD. DNA methyltransferases and pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(3): 345-349 [DOI: 10.11569/wcjd.v22.i3.345] [Reference Citation Analysis]
186 Yokoyama Y, Mizunuma H. Recurrent epithelial ovarian cancer and hormone therapy. World J Clin Cases 2013; 1(6): 187-190 [PMID: 24303498 DOI: 10.12998/wjcc.v1.i6.187] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
187 Wang LJ, Bai L, Jiao SC. The rugged road to targeted therapy for gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(24): 2385-2396 [DOI: 10.11569/wcjd.v21.i24.2385] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
188 Wang HT, Guo HF, Tan XD, Zhang J, Li HS, Yang YF, Wang ZP, Sun Y, Zhang XB. Involvement of plasminogen cascade proteins in the invasion of pancreatic cancer cells. Shijie Huaren Xiaohua Zazhi 2013; 21(23): 2258-2266 [DOI: 10.11569/wcjd.v21.i23.2258] [Reference Citation Analysis]
189 Song J, Peng XL, Ji MY, Ai MH, Zhang JX, Dong WG. Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivoWorld J Gastroenterol 2013; 19(26): 4127-4136 [PMID: 23864775 DOI: 10.3748/wjg.v19.i26.4127] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
190 Xu JM, Wang Y, Ge FJ, Lin L, Liu ZY, Sharma MR. Severe irinotecan-induced toxicity in a patient with UGT1A1*28 and UGT1A1*6 polymorphisms. World J Gastroenterol 2013; 19(24): 3899-3903 [PMID: 23840132 DOI: 10.3748/wjg.v19.i24.3899] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
191 Wu YS, Chen YL, Yin SG, Wang HH. Role of transcription factors in regulation of gene expression in esophageal squamous cell carcinoma. Shijie Huaren Xiaohua Zazhi 2013; 21(16): 1533-1538 [DOI: 10.11569/wcjd.v21.i16.1533] [Reference Citation Analysis]
192 Wang ZK, Yang YS. Upper gastrointestinal microbiota and digestive diseases. World J Gastroenterol 2013; 19(10): 1541-1550 [PMID: 23539678 DOI: 10.3748/wjg.v19.i10.1541] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 63] [Article Influence: 6.1] [Reference Citation Analysis]
193 Huang Z, Chiang Y, Tung M, Wu C, Chen K, Huang M, Wang Y, Shen C. <i>Survivin</i> promoter rs9904341 polymorphism is associated with tumor stage and grade in patients with bladder cancer. ABB 2013;04:1-5. [DOI: 10.4236/abb.2013.41001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
194 Li S, Fu J, Lentzsch S. Cap-Dependent Protein Translation Initiation in Multiple Myeloma: An Attractive Target for Therapy. Genetic and Molecular Epidemiology of Multiple Myeloma 2013. [DOI: 10.1007/978-1-4614-4660-6_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
195 Tanaka T, Fujimura A, Ichimura K, Yanai H, Sato Y, Takata K, Okada H, Kawano S, Tanabe S, Yoshino T. Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma. World J Gastroenterol 2012; 18(43): 6263-6268 [PMID: 23180947 DOI: 10.3748/wjg.v18.i43.6263] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
196 Valle RD, Cerio ALD, Inoges S, Tejada S, Pastor F, Villanueva H, Gallego J, Espinos J, Aristu J, Idoate MA, Andreu E, Bendandi M. Dendritic cell vaccination in glioblastoma after fluorescence-guided resection. World J Clin Oncol 2012; 3(11): 142-149 [PMID: 23293753 DOI: 10.5306/wjco.v3.i11.142] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
197 Erickson HS. Measuring molecular biomarkers in epidemiologic studies: laboratory techniques and biospecimen considerations. Stat Med 2012;31:2400-13. [PMID: 22593027 DOI: 10.1002/sim.4485] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
198 Rameshwar P. Would cancer stem cells affect the future investment in stem cell therapy. World J Exp Med 2012; 2(2): 26-29 [PMID: 24520530 DOI: 10.5493/wjem.v2.i2.26] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
199 Yoneda A, Ito S, Susumu S, Matsuo M, Taniguchi K, Tajima Y, Eguchi S, Kanematsu T, Nagata Y. Immunological milieu in the peritoneal cavity at laparotomy for gastric cancer. World J Gastroenterol 2012; 18(13): 1470-1478 [PMID: 22509078 DOI: 10.3748/wjg.v18.i13.1470] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
200 Mimeault M, Batra SK. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas. World J Clin Oncol 2012; 3(3): 32-42 [PMID: 22442756 DOI: 10.5306/wjco.v3.i3.32] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
201 Scatena R, Bottoni P, Pontoglio A, Scarà S, Giardina B. Cancer Stem Cells: An Innovative Therapeutic Approach. Advances in Cancer Stem Cell Biology 2012. [DOI: 10.1007/978-1-4614-0809-3_15] [Reference Citation Analysis]
202 Church DN, Midgley RS, Kerr DJ. Colorectal Cancer. Biotargets of Cancer in Current Clinical Practice 2012. [DOI: 10.1007/978-1-61779-615-9_9] [Reference Citation Analysis]
203 Cox B, Gibbs IC, Yamada Y. Benign and Malignant Primary Spinal Tumors. Stereotactic Body Radiation Therapy 2012. [DOI: 10.1007/174_2011_534] [Reference Citation Analysis]
204 Paraiso KHT, John JK, Smalley KSM. Melanoma and Other Skin Cancers. Biotargets of Cancer in Current Clinical Practice 2012. [DOI: 10.1007/978-1-61779-615-9_17] [Reference Citation Analysis]
205 Abe H, Kikuchi S, Hayakawa K, Iida T, Nagahashi N, Maeda K, Sakamoto J, Matsumoto N, Miura T, Matsumura K, Seki N, Inaba T, Kawasaki H, Yamaguchi T, Kakefuda R, Nanayama T, Kurachi H, Hori Y, Yoshida T, Kakegawa J, Watanabe Y, Gilmartin AG, Richter MC, Moss KG, Laquerre SG. Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate). ACS Med Chem Lett 2011;2:320-4. [PMID: 24900312 DOI: 10.1021/ml200004g] [Cited by in Crossref: 108] [Cited by in F6Publishing: 114] [Article Influence: 9.0] [Reference Citation Analysis]